Report Detail
Global Anti-inflammatory Medicine for Pets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4744612 |
- 28 September, 2026 |
- Global |
- 124 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Anti-inflammatory Medicine for Pets market size was valued at US$ 1389 million in 2025 and is forecast to a readjusted size of US$ 2060 million by 2032 with a CAGR of 5.9% during review period.
Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 50%.
This report is a detailed and comprehensive analysis for global Anti-inflammatory Medicine for Pets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anti-inflammatory Medicine for Pets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Anti-inflammatory Medicine for Pets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Anti-inflammatory Medicine for Pets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Anti-inflammatory Medicine for Pets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-inflammatory Medicine for Pets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-inflammatory Medicine for Pets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Anti-inflammatory Medicine for Pets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Powder
Liquid
Market segment by Application
Cat
Dog
Reptile
Other
Major players covered
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Wuhan chopperlvya
CAHIC
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-inflammatory Medicine for Pets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-inflammatory Medicine for Pets, with price, sales quantity, revenue, and global market share of Anti-inflammatory Medicine for Pets from 2021 to 2026.
Chapter 3, the Anti-inflammatory Medicine for Pets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-inflammatory Medicine for Pets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Anti-inflammatory Medicine for Pets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-inflammatory Medicine for Pets.
Chapter 14 and 15, to describe Anti-inflammatory Medicine for Pets sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Anti-inflammatory Medicine for Pets Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Powder
- 1.3.3 Liquid
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Anti-inflammatory Medicine for Pets Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Cat
- 1.4.3 Dog
- 1.4.4 Reptile
- 1.4.5 Other
- 1.5 Global Anti-inflammatory Medicine for Pets Market Size & Forecast
- 1.5.1 Global Anti-inflammatory Medicine for Pets Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Anti-inflammatory Medicine for Pets Sales Quantity (2021-2032)
- 1.5.3 Global Anti-inflammatory Medicine for Pets Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Zoetis
- 2.1.1 Zoetis Details
- 2.1.2 Zoetis Major Business
- 2.1.3 Zoetis Anti-inflammatory Medicine for Pets Product and Services
- 2.1.4 Zoetis Anti-inflammatory Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Zoetis Recent Developments/Updates
- 2.2 Boehringer Ingelheim
- 2.2.1 Boehringer Ingelheim Details
- 2.2.2 Boehringer Ingelheim Major Business
- 2.2.3 Boehringer Ingelheim Anti-inflammatory Medicine for Pets Product and Services
- 2.2.4 Boehringer Ingelheim Anti-inflammatory Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Boehringer Ingelheim Recent Developments/Updates
- 2.3 Merck
- 2.3.1 Merck Details
- 2.3.2 Merck Major Business
- 2.3.3 Merck Anti-inflammatory Medicine for Pets Product and Services
- 2.3.4 Merck Anti-inflammatory Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Merck Recent Developments/Updates
- 2.4 Elanco
- 2.4.1 Elanco Details
- 2.4.2 Elanco Major Business
- 2.4.3 Elanco Anti-inflammatory Medicine for Pets Product and Services
- 2.4.4 Elanco Anti-inflammatory Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Elanco Recent Developments/Updates
- 2.5 Virbac
- 2.5.1 Virbac Details
- 2.5.2 Virbac Major Business
- 2.5.3 Virbac Anti-inflammatory Medicine for Pets Product and Services
- 2.5.4 Virbac Anti-inflammatory Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Virbac Recent Developments/Updates
- 2.6 Dechra Veterinary Products
- 2.6.1 Dechra Veterinary Products Details
- 2.6.2 Dechra Veterinary Products Major Business
- 2.6.3 Dechra Veterinary Products Anti-inflammatory Medicine for Pets Product and Services
- 2.6.4 Dechra Veterinary Products Anti-inflammatory Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Dechra Veterinary Products Recent Developments/Updates
- 2.7 Ceva
- 2.7.1 Ceva Details
- 2.7.2 Ceva Major Business
- 2.7.3 Ceva Anti-inflammatory Medicine for Pets Product and Services
- 2.7.4 Ceva Anti-inflammatory Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Ceva Recent Developments/Updates
- 2.8 Vetoquinol
- 2.8.1 Vetoquinol Details
- 2.8.2 Vetoquinol Major Business
- 2.8.3 Vetoquinol Anti-inflammatory Medicine for Pets Product and Services
- 2.8.4 Vetoquinol Anti-inflammatory Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Vetoquinol Recent Developments/Updates
- 2.9 Ouro Fino Saude
- 2.9.1 Ouro Fino Saude Details
- 2.9.2 Ouro Fino Saude Major Business
- 2.9.3 Ouro Fino Saude Anti-inflammatory Medicine for Pets Product and Services
- 2.9.4 Ouro Fino Saude Anti-inflammatory Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Ouro Fino Saude Recent Developments/Updates
- 2.10 Norbrook
- 2.10.1 Norbrook Details
- 2.10.2 Norbrook Major Business
- 2.10.3 Norbrook Anti-inflammatory Medicine for Pets Product and Services
- 2.10.4 Norbrook Anti-inflammatory Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Norbrook Recent Developments/Updates
- 2.11 Jindun
- 2.11.1 Jindun Details
- 2.11.2 Jindun Major Business
- 2.11.3 Jindun Anti-inflammatory Medicine for Pets Product and Services
- 2.11.4 Jindun Anti-inflammatory Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Jindun Recent Developments/Updates
- 2.12 Wuhan chopperlvya
- 2.12.1 Wuhan chopperlvya Details
- 2.12.2 Wuhan chopperlvya Major Business
- 2.12.3 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Product and Services
- 2.12.4 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Wuhan chopperlvya Recent Developments/Updates
- 2.13 CAHIC
- 2.13.1 CAHIC Details
- 2.13.2 CAHIC Major Business
- 2.13.3 CAHIC Anti-inflammatory Medicine for Pets Product and Services
- 2.13.4 CAHIC Anti-inflammatory Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 CAHIC Recent Developments/Updates
3 Competitive Environment: Anti-inflammatory Medicine for Pets by Manufacturer
- 3.1 Global Anti-inflammatory Medicine for Pets Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Anti-inflammatory Medicine for Pets Revenue by Manufacturer (2021-2026)
- 3.3 Global Anti-inflammatory Medicine for Pets Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Anti-inflammatory Medicine for Pets by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Anti-inflammatory Medicine for Pets Manufacturer Market Share in 2025
- 3.4.3 Top 6 Anti-inflammatory Medicine for Pets Manufacturer Market Share in 2025
- 3.5 Anti-inflammatory Medicine for Pets Market: Overall Company Footprint Analysis
- 3.5.1 Anti-inflammatory Medicine for Pets Market: Region Footprint
- 3.5.2 Anti-inflammatory Medicine for Pets Market: Company Product Type Footprint
- 3.5.3 Anti-inflammatory Medicine for Pets Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Anti-inflammatory Medicine for Pets Market Size by Region
- 4.1.1 Global Anti-inflammatory Medicine for Pets Sales Quantity by Region (2021-2032)
- 4.1.2 Global Anti-inflammatory Medicine for Pets Consumption Value by Region (2021-2032)
- 4.1.3 Global Anti-inflammatory Medicine for Pets Average Price by Region (2021-2032)
- 4.2 North America Anti-inflammatory Medicine for Pets Consumption Value (2021-2032)
- 4.3 Europe Anti-inflammatory Medicine for Pets Consumption Value (2021-2032)
- 4.4 Asia-Pacific Anti-inflammatory Medicine for Pets Consumption Value (2021-2032)
- 4.5 South America Anti-inflammatory Medicine for Pets Consumption Value (2021-2032)
- 4.6 Middle East & Africa Anti-inflammatory Medicine for Pets Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Anti-inflammatory Medicine for Pets Sales Quantity by Type (2021-2032)
- 5.2 Global Anti-inflammatory Medicine for Pets Consumption Value by Type (2021-2032)
- 5.3 Global Anti-inflammatory Medicine for Pets Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Anti-inflammatory Medicine for Pets Sales Quantity by Application (2021-2032)
- 6.2 Global Anti-inflammatory Medicine for Pets Consumption Value by Application (2021-2032)
- 6.3 Global Anti-inflammatory Medicine for Pets Average Price by Application (2021-2032)
7 North America
- 7.1 North America Anti-inflammatory Medicine for Pets Sales Quantity by Type (2021-2032)
- 7.2 North America Anti-inflammatory Medicine for Pets Sales Quantity by Application (2021-2032)
- 7.3 North America Anti-inflammatory Medicine for Pets Market Size by Country
- 7.3.1 North America Anti-inflammatory Medicine for Pets Sales Quantity by Country (2021-2032)
- 7.3.2 North America Anti-inflammatory Medicine for Pets Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Anti-inflammatory Medicine for Pets Sales Quantity by Type (2021-2032)
- 8.2 Europe Anti-inflammatory Medicine for Pets Sales Quantity by Application (2021-2032)
- 8.3 Europe Anti-inflammatory Medicine for Pets Market Size by Country
- 8.3.1 Europe Anti-inflammatory Medicine for Pets Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Anti-inflammatory Medicine for Pets Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Anti-inflammatory Medicine for Pets Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Anti-inflammatory Medicine for Pets Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Anti-inflammatory Medicine for Pets Market Size by Region
- 9.3.1 Asia-Pacific Anti-inflammatory Medicine for Pets Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Anti-inflammatory Medicine for Pets Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Anti-inflammatory Medicine for Pets Sales Quantity by Type (2021-2032)
- 10.2 South America Anti-inflammatory Medicine for Pets Sales Quantity by Application (2021-2032)
- 10.3 South America Anti-inflammatory Medicine for Pets Market Size by Country
- 10.3.1 South America Anti-inflammatory Medicine for Pets Sales Quantity by Country (2021-2032)
- 10.3.2 South America Anti-inflammatory Medicine for Pets Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Anti-inflammatory Medicine for Pets Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Anti-inflammatory Medicine for Pets Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Anti-inflammatory Medicine for Pets Market Size by Country
- 11.3.1 Middle East & Africa Anti-inflammatory Medicine for Pets Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Anti-inflammatory Medicine for Pets Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Anti-inflammatory Medicine for Pets Market Drivers
- 12.2 Anti-inflammatory Medicine for Pets Market Restraints
- 12.3 Anti-inflammatory Medicine for Pets Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Anti-inflammatory Medicine for Pets and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Anti-inflammatory Medicine for Pets
- 13.3 Anti-inflammatory Medicine for Pets Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Anti-inflammatory Medicine for Pets Typical Distributors
- 14.3 Anti-inflammatory Medicine for Pets Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Anti-inflammatory Medicine for Pets. Industry analysis & Market Report on Anti-inflammatory Medicine for Pets is a syndicated market report, published as Global Anti-inflammatory Medicine for Pets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Anti-inflammatory Medicine for Pets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
